NUI Galway is expanding its international collaboration on high end medical research with a stem cell research centre in...
Samsung Bioepis Co., Ltd. has announced that its rapidly growing biosimilar business will expand into mainland China thr...
Sandoz, recently announced that it has entered into an agreement with Gan & Lee Pharmaceutical to commerci...
OrigiMed Co., Ltd., has formally announced the completion of its Series B financing. This round of financing is le...
China's leading one-stop healthcare ecosystem platform Ping An Health Medical Technology Company Limited has releas...
ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announce...
Antengene, a Shanghai based clinical stage therapeutics company focused on oncology has announced that it has completed ...
Connect Biopharmaceuticals, a clinical-stage company that discovers and develops novel immune modulators for the treatme...
HJB and MabSpace Biosciences (MabSpace) today announced that the two companies have entered into a definitive merge...
The National Accreditation Board for Certification Bodies (NABCB), India’s national accreditation body, has secure...
Zai Lab today announced the launch of Optune (Tumor Treating Fields or TTFields) in Hong Kong ...
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecul...
Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovativ...
Singapore – OUE Lippo Healthcare Limited announced that its 50:50 joint venture company with China Merch...
InventisBio announced that it has signed a "Collaboration Agreement" with Betta Pharma. Under this agreement, Inve...
MEDI FUTURES, a biomedical ultrasound company and a member company of the K-ICT Born2Global Centre, successfully at...
JHL Biotech announced today that the first patient at Beijing Cancer Hospital has been successfully randomized in t...
Innovent Biologics and Eli Lilly and Company have jointly announced that the co-developed Tyvyt (fully human anti-PD-1 t...
